Results for
"[search-keyword]"
Sponsor content
179 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FRUZAQLA fruquintinib 1 mg hard capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FRUZAQLA fruquintinib 5 mg hard capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Takeda Pharmaceuticals Australia Pty Ltd - Syringe, general-purpose.
-
Prescription medicine registrationActive ingredients: fruquintinib.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TAKHZYRO lanadelumab 150 mg/1 mL solution for injection pre-filled syringe.
-
Prescription medicine registrationActive ingredients: lanadelumab.
-
Australian Public Assessment Report (AusPAR)Adcetris (brentuximab vedotin) has been approved for the treatment of Hodgkin lymphoma in patients with previously untreated CD30+ Stage III or Stage IV Hodgkin lymphoma.
-
May-2024Prescription medicine evaluationActive ingredient: normal immunoglobulin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Takeda Pharmaceuticals Australia Pty Ltd - Medication transfer set.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Takeda Pharmaceuticals Australia Pty Ltd - Subcutaneous/intramuscular injection set, medicated.